Press Releases



 
Press Releases
  Date Title View
Feb 10, 2006
REDWOOD CITY, Calif., Feb 10, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., the Company's Chairman and Chief Executive Officer will present at the 2006 BIO CEO & Investor Conference on Wednesday, February 15, 2006 at 10:00 a.m. Eastern at the Waldorf-Astoria in N...
PDF
Feb 6, 2006
REDWOOD CITY, Calif., Feb 06, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Monday, February 13, 2006 at 4:30 PM Eastern Time to discuss its fourth quarter and year end 2005 financial results. The call and webcast will follow th...
PDF
Jan 27, 2006
REDWOOD CITY, Calif., Jan 27, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that it has received a letter from the Food and Drug Administration (FDA) regarding Oncotype DX(TM), the company's genomic-based test for early stage breast cancer patients. The letter invited the company to meet...
PDF
Jan 13, 2006
REDWOOD CITY, Calif., Jan 13, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the National Heritage Insurance Company (NHIC), the contractor that administers Medicare programs in California, has established a positive coverage policy for the company's Oncotype DX(TM) breast cancer tes...
PDF
Jan 5, 2006
REDWOOD CITY, Calif., Jan 05, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., the Company's Chairman and Chief Executive Officer, will present at the 24th Annual JPMorgan Healthcare Conference on Monday, January 9, 2006 at 3:30 PM Pacific (6:30 PM Eastern) at the W...
PDF
Dec 10, 2005
SAN ANTONIO, Dec 10, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from a new analysis demonstrating that the same Oncotype DX(TM) Recurrence Score(TM) that quantifies distant recurrence for a large portion of early-stage breast cancer patients is also a significant pred...
PDF
Dec 9, 2005
SAN ANTONIO, Dec 09, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of a community-based, investigator-sponsored study that demonstrated its Oncotype DX(TM) 21-gene panel breast cancer test, which quantifies the likelihood of recurrence and predicts chemotherapy benefit for a larg...
PDF
Dec 5, 2005
REDWOOD CITY, Calif., Dec 05, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that results from three new analyses of the company's Oncotype DX(TM) breast cancer test, which quantifies the likelihood of recurrence and predicts chemotherapy benefit for a large portion of early stage breast ...
PDF
Nov 3, 2005
REDWOOD CITY, Calif., Nov 03, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results for the third quarter and nine months ended September 30, 2005. Total revenue was $1,592,000 in the third quarter of 2005, compared to $167,000 in the third quarter of 2004, driven by growth of O...
PDF
Oct 28, 2005
REDWOOD CITY, Calif., Oct 28, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Thursday, November 3 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its third quarter 2005 financial results. The call and webcast will foll...
PDF
FirstPrevious
...
38
NextLast